Medication Options & Crucial Safety Considerations
At a Glance
For epilepsy with generalized tonic-clonic seizures alone, valproate can be highly effective but has serious pregnancy risks; levetiracetam and lamotrigine are common alternatives, and medication choice should account for seizure control, side effects, and birth-control interactions.
Choosing a medication for Epilepsy with generalized tonic-clonic seizures alone (EGTCSA or EGTCA) involves balancing the goal of complete seizure freedom with the need for long-term safety, side effect management, and family planning. Because this is a generalized epilepsy, your brain requires medications that can stabilize electrical activity across widespread networks rather than just one spot [1]. Note: You should seek specialist advice before using narrow-spectrum drugs that can aggravate generalized seizure types, such as carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, tiagabine, or vigabatrin.
The Role of Valproate
Valproate (also known as sodium valproate or valproic acid) is often considered highly effective for stopping generalized tonic-clonic seizures [1]. In some clinical studies of generalized epilepsies, it has shown superior 12-month seizure-free rates compared to some other options, such as lamotrigine (e.g., 76.7% vs 56.7%, though comparative results depend heavily on the specific study population and outcomes) [2].
However, despite its effectiveness, valproate is rarely used as a first-line choice for people who can become pregnant due to serious safety concerns [3].
Critical Safety: Valproate and Pregnancy
If you are someone who could become pregnant, the risks associated with valproate are significant and must be discussed with your specialist.
- Physical Malformations: Exposure to valproate during pregnancy is associated with a high risk (approximately 10.3%) of major birth defects, including neural tube defects (like spina bifida), compared to about 3% for other medications [3][4].
- Neurodevelopmental Risks: Children exposed to valproate in the womb have a significantly higher risk of autism spectrum disorder, intellectual disability, and lower IQ scores compared to those exposed to other epilepsy drugs [5].
- Risk Mitigation: Clinical guidelines advise avoiding valproate in people who can become pregnant unless all other treatments have failed or are not tolerated [3]. Depending on your local jurisdiction, you may be required to join a structured “pregnancy prevention program” and use highly effective contraception [6]. Discuss preconception counseling and folic acid supplementation with your doctor.
- Urgent Warning: If you are taking valproate and discover you are pregnant, contact your prescriber promptly. Do not stop taking valproate abruptly, as sudden withdrawal can trigger life-threatening seizures.
Alternative First-Line Options
For many patients, especially those who must avoid valproate, doctors recommend levetiracetam or lamotrigine [1]. The choice depends on seizure confirmation, age, pregnancy potential, mood, and personal priorities.
- Levetiracetam: This is a popular alternative because it works quickly and does not typically interact with other medications. In some studies, it has shown high seizure-control rates comparable to valproate (approximately 80-88% in some cohorts) [7][8].
- Side Effect Watch: The most common reason people stop taking levetiracetam is behavioral side effects, such as irritability, anger, mood swings, or suicidal thoughts [9]. Contact your doctor if you experience significant mood changes.
- Lamotrigine: This medication is often better tolerated in terms of mood and weight, but it must be started very slowly to avoid a rare but serious allergic rash [3].
- Urgent Warning: A new rash—especially with blistering, mucosal sores, fever, facial swelling, or peeling skin—requires urgent medical advice.
- Side Effect Watch: In some cases of generalized epilepsy, lamotrigine can unexpectedly worsen certain types of seizures like myoclonic jerks [10]. It also has a particularly important dose interaction if used alongside valproate.
Drug Interactions and Birth Control
Your epilepsy medication and your hormonal birth control can sometimes interfere with each other. This is a crucial safety conversation to have with your doctor. Check with a pharmacist before adding contraception, supplements, or over-the-counter medicines.
| Medication | Interaction with Birth Control |
|---|---|
| Lamotrigine | Estrogen-containing birth control can lower your lamotrigine levels by more than 50%, potentially leading to breakthrough seizures [11]. |
| Topiramate | At higher doses, this enzyme-inducing drug can make oral birth control pills less effective, increasing the risk of an unplanned pregnancy (interaction thresholds depend on formulation and dose) [12]. |
| Valproate | Does not make birth control less effective, but reliable contraception and preconception planning are critical due to severe fetal risks [11]. |
| Levetiracetam | Generally does not interact with hormonal birth control [11]. |
Other Options: Topiramate
Topiramate is another effective option for generalized seizures, but it is often used as a second-line choice because of its side-effect profile [13].
- Cognitive Effects: It is well-known for causing cognitive “brain fog,” difficulty finding words, and memory issues [13].
- Physical Effects: It can cause weight loss, metabolic acidosis, kidney stones, heat-related illness, acute eye symptoms, and a tingling sensation in the hands and feet [13]. Like valproate, it also carries neurodevelopmental risks and a higher risk of birth defects and should be used with caution during childbearing years [14].
Note: Never stop or change your epilepsy medication without medical supervision, as doing so can trigger severe, continuous seizures [15].
Common questions in this guide
Which medicines are commonly used for epilepsy with generalized tonic-clonic seizures alone?
Is valproate a good option if I could become pregnant?
What should I do if I develop a rash while taking lamotrigine?
Can my epilepsy medicine affect hormonal birth control?
What mood changes can levetiracetam cause?
Should I stop my epilepsy medicine if I become pregnant?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my diagnosis, is valproate the most effective option, or should we start with levetiracetam or lamotrigine to avoid long-term risks?
- 2.If we use lamotrigine, what specific rash symptoms require an immediate trip to the emergency room?
- 3.I am using hormonal birth control; will my epilepsy medication make it less effective, or will my birth control lower my medication levels?
- 4.What are the specific local regulations regarding pregnancy prevention programs for the medication you are prescribing?
- 5.If I experience changes in my mood or personality while taking levetiracetam, how quickly should I contact your office?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ, Sudell M, Cividini S, et al.
The Cochrane database of systematic reviews 2022; (4()):CD011412 doi:10.1002/14651858.CD011412.pub4.
PMID: 35363878 - 2
Valproic Acid versus Lamotrigine as First-line Monotherapy in Newly Diagnosed Idiopathic Generalized Tonic -Clonic Seizures in Adults - A Randomized Controlled Trial.
Giri VP, Giri OP, Khan FA, et al.
Journal of clinical and diagnostic research : JCDR 2016; (10(7)):FC01-4 doi:10.7860/JCDR/2016/16911.8121.
PMID: 27630862 - 3
Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T, Marson A, Boon P, et al.
Epilepsia 2015; (56(7)):1006-19 doi:10.1111/epi.13021.
PMID: 25851171 - 4
Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs.
Blotière PO, Raguideau F, Weill A, et al.
Neurology 2019; (93(2)):e167-e180 doi:10.1212/WNL.0000000000007696.
PMID: 31189695 - 5
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
Bjørk MH, Zoega H, Leinonen MK, et al.
JAMA neurology 2022; (79(7)):672-681 doi:10.1001/jamaneurol.2022.1269.
PMID: 35639399 - 6
National compliance with UK wide guidelines for usage of valproate in women of childbearing potential.
Eriksson SH, Tittensor P, Sisodiya SM
Seizure 2022; (98()):8-12 doi:10.1016/j.seizure.2022.03.020.
PMID: 35395505 - 7
Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Tabrizi N, Zarvani A, Rezaei P, et al.
Epilepsy research 2019; (157()):106214 doi:10.1016/j.eplepsyres.2019.106214.
PMID: 31627041 - 8
Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
Abdelmesih SK, Elkhateeb N, Zakaria M, Girgis MY
Seizure 2021; (91()):263-270 doi:10.1016/j.seizure.2021.06.033.
PMID: 34246881 - 9
Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
Ballvé A, Salas-Puig J, Quintana M, et al.
Acta neurologica Scandinavica 2021; (143(4)):407-412 doi:10.1111/ane.13389.
PMID: 33452703 - 10
Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
Gesche J, Hjalgrim H, Rubboli G, Beier CP
Epilepsy research 2021; (170()):106547 doi:10.1016/j.eplepsyres.2020.106547.
PMID: 33421702 - 11
Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
Serafini A, Gerard E, Genton P, et al.
CNS drugs 2019; (33(3)):195-208 doi:10.1007/s40263-018-00602-2.
PMID: 30747367 - 12
Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.
Stephen LJ, Brodie MJ
CNS drugs 2020; (34(2)):147-161 doi:10.1007/s40263-020-00698-5.
PMID: 31983023 - 13
Anticonvulsant drugs for generalized tonic-clonic epilepsy.
Coppola G, Piccorossi A, Operto FF, Verrotti A
Expert opinion on pharmacotherapy 2017; (18(9)):925-936 doi:10.1080/14656566.2017.1328499.
PMID: 28481729 - 14
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM.
Pack AM, Oskoui M, Williams Roberson S, et al.
Neurology 2024; (102(11)):e209279 doi:10.1212/WNL.0000000000209279.
PMID: 38748979 - 15
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, et al.
Lancet (London, England) 2021; (397(10282)):1375-1386 doi:10.1016/S0140-6736(21)00246-4.
PMID: 33838758
This page is for informational purposes only and does not constitute medical advice about EGTCA medication choices. Ask your neurologist or prescriber before starting, stopping, or changing treatment, and contact them promptly about pregnancy or serious side effects.
Get notified when new evidence is published on Epilepsy with generalized tonic-clonic seizures alone.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.